2.58
price down icon0.06%   -0.010
 
loading
전일 마감가:
$2.59
열려 있는:
$2.58
하루 거래량:
156.06K
Relative Volume:
0.63
시가총액:
$99.24M
수익:
$1.50M
순이익/손실:
$-81.41M
주가수익비율:
-0.3963
EPS:
-6.51
순현금흐름:
$-43.75M
1주 성능:
-10.44%
1개월 성능:
-13.14%
6개월 성능:
+3.12%
1년 성능:
+6.08%
1일 변동 폭
Value
$2.55
$2.61
1주일 범위
Value
$2.55
$2.8999
52주 변동 폭
Value
$1.68
$5.00

립 테라퓨틱스 Stock (LPTX) Company Profile

Name
명칭
Leap Therapeutics Inc
Name
전화
617 252 4343
Name
주소
47 THORNDIKE STREET, CAMBRIDGE, MA
Name
직원
54
Name
트위터
@LeapTherapeutic
Name
다음 수익 날짜
2024-11-11
Name
최신 SEC 제출 서류
Name
LPTX's Discussions on Twitter

LPTX을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
LPTX 2.5884 99.24M 1.50M -81.41M -43.75M -6.51
VRTX 450.26 115.43B 10.63B -479.80M -1.35B 13.33
REGN 746.04 82.04B 13.85B 4.65B 3.32B 35.06
ARGX 591.88 35.30B 1.86B -40.29M -1.28B -4.16
ALNY 245.32 32.04B 2.09B -332.26M 16.06M -4.14
BNTX 107.56 24.89B 3.30B -501.07M 1.03B 11.54

립 테라퓨틱스 Stock (LPTX) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2021-10-04 개시 Mizuho Buy
2021-06-04 재개 Robert W. Baird Outperform
2020-06-29 개시 Piper Sandler Overweight
2020-02-11 개시 Robert W. Baird Outperform
2019-11-15 다운그레이드 Raymond James Outperform → Mkt Perform
2019-09-13 재개 Raymond James Outperform
2017-03-07 개시 Ladenburg Thalmann Buy
모두보기

립 테라퓨틱스 주식(LPTX)의 최신 뉴스

pulisher
Nov 19, 2024

HC Wainwright Reaffirms Buy Rating for Leap Therapeutics (NASDAQ:LPTX) - Defense World

Nov 19, 2024
pulisher
Nov 18, 2024

HCW Biologics Inc. (HCWB): A Strategic Leap with Worldwide Licensing Agreement Sends Stock Up Over 310% - BP Journal

Nov 18, 2024
pulisher
Nov 15, 2024

Simplify Asset Management Inc. Acquires 425,626 Shares of Leap Therapeutics, Inc. (NASDAQ:LPTX) - MarketBeat

Nov 15, 2024
pulisher
Nov 15, 2024

Balyasny Asset Management L.P. Reduces Stake in Leap Therapeutics Inc - GuruFocus.com

Nov 15, 2024
pulisher
Nov 13, 2024

Leap Therapeutics Reports Third Quarter 2024 Financial Results - citybiz

Nov 13, 2024
pulisher
Nov 13, 2024

Leap Therapeutics Reports Wider Q3 Loss, Advances Cancer Drug Trials with $62.8M Cash | LPTX Stock News - StockTitan

Nov 13, 2024
pulisher
Nov 13, 2024

Liquor, Wine, Beer: Which Comes With the Worst Lifestyle? - 69News WFMZ-TV

Nov 13, 2024
pulisher
Nov 07, 2024

Sparked by FDA expansion, Sarepta's Elevidys takes another leap in sales - FiercePharma

Nov 07, 2024
pulisher
Nov 02, 2024

Sermonix Pharmaceuticals’ Lasofoxifene Is Well Tolerated, - GlobeNewswire

Nov 02, 2024
pulisher
Nov 01, 2024

DKN-01 With Tislelizumab and Chemotherapy in Advanced Gastric or Gastroesophageal Junction Adenocarcinoma - The ASCO Post

Nov 01, 2024
pulisher
Oct 27, 2024

Leap Therapeutics, Inc. (NASDAQ:LPTX) Sees Large Decline in Short Interest - MarketBeat

Oct 27, 2024
pulisher
Oct 27, 2024

Spero Therapeutics, Inc. (NASDAQ:SPRO) Stock Has Shown Weakness Lately But Financials Look Strong: Should Prospective Shareholders Make The Leap? - Yahoo Finance

Oct 27, 2024
pulisher
Oct 25, 2024

Payment processor Finix secures $75m in Series C funding - Electronic Payments International

Oct 25, 2024
pulisher
Oct 18, 2024

Astellas nabs class-first FDA approval for CLDN18.2 gastric cancer med Vyloy - FiercePharma

Oct 18, 2024
pulisher
Oct 17, 2024

Dow Jones notches new record, chip stocks leap higher - Yahoo Finance

Oct 17, 2024
pulisher
Oct 14, 2024

Marshall Wace LLP Acquires New Stake in ChromaDex Co. (NASDAQ:CDXC) - Defense World

Oct 14, 2024
pulisher
Oct 14, 2024

Profire Energy, Inc. (NASDAQ:PFIE) Shares Sold by Marshall Wace LLP - Defense World

Oct 14, 2024
pulisher
Oct 14, 2024

Marshall Wace LLP Makes New Investment in Vivid Seats Inc. (NASDAQ:SEAT) - Defense World

Oct 14, 2024
pulisher
Oct 04, 2024

Venous Leg Ulcers Treatment Market value, Innovations Driving Market Evolution (2024-2036) - Third Eye News

Oct 04, 2024
pulisher
Oct 01, 2024

Leap Therapeutics Announces Completion of Enrollment in Part B of the DeFianCe Study of DKN-01 for the Treatment of Colorectal Cancer Patients - The Malaysian Reserve

Oct 01, 2024
pulisher
Sep 30, 2024

LPTXLeap Therapeutics, Inc. Latest Stock News & Market Updates - StockTitan

Sep 30, 2024
pulisher
Sep 30, 2024

Venous Leg Ulcers Treatment Market Growth, Size, Research Report and Forecast (2024-2034) - Talented India

Sep 30, 2024
pulisher
Sep 28, 2024

Leap Therapeutics (NASDAQ:LPTX) Share Price Passes Below 50 Day Moving Average of $2.58 - MarketBeat

Sep 28, 2024
pulisher
Sep 25, 2024

Biliary Tract Cancer Pipeline Analysis 2024: FDA Approvals - openPR

Sep 25, 2024
pulisher
Sep 25, 2024

TSX Communication Services Capped Index (TTTS) QuotePress Release - The Globe and Mail

Sep 25, 2024
pulisher
Sep 20, 2024

Simplify Asset Management Inc. Has $1.24 Million Stock Position in Leap Therapeutics, Inc. (NASDAQ:LPTX) - MarketBeat

Sep 20, 2024
pulisher
Sep 20, 2024

Simplify Asset Management Inc. Buys 255,293 Shares of Leap Therapeutics, Inc. (NASDAQ:LPTX) - Defense World

Sep 20, 2024
pulisher
Sep 20, 2024

Meiji Yasuda Asset Management Co Ltd. Has $1.22 Million Stock Position in Hilton Worldwide Holdings Inc. (NYSE:HLT) - Defense World

Sep 20, 2024
pulisher
Sep 19, 2024

Commonwealth Equity Services LLC Boosts Position in AllianzIM U.S. Large Cap Buffer10 Sep ETF (NYSEARCA:SEPT) - Defense World

Sep 19, 2024
pulisher
Sep 19, 2024

Newmark Security (LON:NWT) Stock Price Crosses Above Two Hundred Day Moving Average of $91.75 - Defense World

Sep 19, 2024
pulisher
Sep 17, 2024

How Analyst Ratings Affect Leap Therapeutics Inc Inc. (LPTX) Price Performance - The InvestChronicle

Sep 17, 2024
pulisher
Sep 16, 2024

Advances in Sickle Cell Disease: New Gene Therapies and Management Strategies - Pharmacy Times

Sep 16, 2024
pulisher
Sep 10, 2024

Vivos Therapeutics, Inc.'s (NASDAQ:VVOS) Shares Leap 41% Yet They're Still Not Telling The Full Story - Simply Wall St

Sep 10, 2024
pulisher
Sep 06, 2024

Lilly adds to genetic meds push with Genetic Leap alliance - pharmaphorum

Sep 06, 2024
pulisher
Sep 05, 2024

Genetic Leap and Lilly Enter Collaboration to Accelerate Genetic Medicine Development with AI - PR Newswire

Sep 05, 2024
pulisher
Sep 05, 2024

Vera Therapeutics (NASDAQ:VERA) vs. Pivotal Therapeutics (OTCMKTS:PVTTF) Financial Analysis - Defense World

Sep 05, 2024
pulisher
Sep 03, 2024

Global Gastric Cancer Diagnostics Market is Expected to Expand at a CAGR of ~7% by 2030 | DelveInsight - PR Newswire UK

Sep 03, 2024
pulisher
Sep 03, 2024

ORKA Stock Price and Chart — NASDAQ:ORKA - TradingView

Sep 03, 2024
pulisher
Sep 02, 2024

Lululemon Athletica (NASDAQ:LULU) Price Target Lowered to $326.00 at Morgan Stanley - Defense World

Sep 02, 2024
pulisher
Sep 02, 2024

Farther Finance Advisors LLC Has $1.20 Million Stake in Paychex, Inc. (NASDAQ:PAYX) - Defense World

Sep 02, 2024
pulisher
Sep 02, 2024

Laramide Resources Ltd. (TSE:LAM) Director Buys C$10,200.00 in Stock - Defense World

Sep 02, 2024
pulisher
Sep 02, 2024

Rothschild Investment LLC Buys Shares of 8,904 Capital Group Growth ETF (NYSEARCA:CGGR) - Defense World

Sep 02, 2024
pulisher
Sep 02, 2024

Picton Mahoney Asset Management Takes $71,000 Position in American Woodmark Co. (NASDAQ:AMWD) - Defense World

Sep 02, 2024
pulisher
Sep 02, 2024

Rothschild Investment LLC Makes New Investment in iShares Core MSCI Europe ETF (NYSEARCA:IEUR) - Defense World

Sep 02, 2024
pulisher
Sep 02, 2024

Farther Finance Advisors LLC Has $1.36 Million Stake in McKesson Co. (NYSE:MCK) - Defense World

Sep 02, 2024
pulisher
Sep 02, 2024

Intel Co. (NASDAQ:INTC) Shares Purchased by Farther Finance Advisors LLC - Defense World

Sep 02, 2024
pulisher
Sep 02, 2024

Rothschild Investment LLC Takes Position in BlackRock MuniHoldings Quality Fund II, Inc. (NYSE:MUE) - Defense World

Sep 02, 2024
pulisher
Sep 02, 2024

BNP PARIBAS ASSET MANAGEMENT Holding S.A. Trims Stock Holdings in Universal Health Services, Inc. (NYSE:UHS) - Defense World

Sep 02, 2024
pulisher
Sep 02, 2024

Allspring Global Investments Holdings LLC Sells 103,605 Shares of Wabash National Co. (NYSE:WNC) - Defense World

Sep 02, 2024
pulisher
Aug 31, 2024

Leap Therapeutics, Inc. (NASDAQ:LPTX) Short Interest Update - MarketBeat

Aug 31, 2024
pulisher
Aug 27, 2024

Sermonix Pharmaceuticals Completes Enrollment of Phase 2 - GlobeNewswire

Aug 27, 2024

립 테라퓨틱스 (LPTX) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$18.98
price up icon 1.80%
$70.68
price down icon 0.42%
$38.38
price up icon 3.49%
$369.83
price up icon 1.48%
$196.58
price up icon 0.88%
$102.64
price up icon 0.27%
자본화:     |  볼륨(24시간):